✦ LIBER ✦
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
✍ Scribed by C. Balañá, M. A. Vaz, D. Lopez, R. de la Peñas…
- Book ID
- 120902461
- Publisher
- Springer Milan
- Year
- 2013
- Tongue
- Spanish
- Weight
- 295 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1699-048X
No coin nor oath required. For personal study only.